Baxter International develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The Company operates through three segments: BioScience, Medication Delivery, and Renal. It offers peritoneal dialysis and hemodialysis, renal replacement therapies and other organ support therapies, sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, drug reconstitution devices, and parenteral nutrition therapies.
TypePublic
HQDeerfield, US
Founded1931
Size (employees)47,000 (est)-2%
Websitebaxter.com
Baxter International was founded in 1931 and is headquartered in Deerfield, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Baxter International

Jose Almeida

Jose Almeida

Chairman, President and Chief Executive Officer
John Forsyth

John Forsyth

Chairman and Chief Executive Officer, Wellmark Blue Cross and Blue Shield
James Gavin

James Gavin

Chief Executive Officer and Chief Medical Officer, Healing Our Village, Inc
Munib Islam

Munib Islam

Partner and Head of Equities Research, Third Point LLC
Michael Mahoney

Michael Mahoney

Chairman, President and Chief Executive Officer, Boston Scientific Corporation
Cathy Smith

Cathy Smith

Executive Vice President and Chief Financial Officer, Target Corporation
Show more

Baxter International Office Locations

Baxter International has offices in Lombard, Houston, Baltimore, Bloomington and in 34 other locations
Deerfield, US (HQ)
One Baxter Parkway
Show all (38)
Report incorrect company information

Baxter International Financials and Metrics

Baxter International Revenue

Embed Graph
Baxter International's revenue was reported to be $10.16 b in FY, 2016 which is a 2% increase from the previous period.
USD

Revenue (Q2, 2018)

5.5 b

Gross profit (Q2, 2018)

2.4 b

Gross profit margin (Q2, 2018), %

42.6%

Net income (Q2, 2018)

732 m

EBIT (Q2, 2018)

816 m

Market capitalization (20-Sep-2018)

41.5 b

Closing stock price (20-Sep-2018)

77.7

Cash (30-Jun-2018)

2.9 b
Baxter International's current market capitalization is $41.5 b.
Annual
USDFY, 2015FY, 2016

Revenue

10 b10.2 b

Revenue growth, %

(40%)2%

Cost of goods sold

5.8 b6.1 b

Gross profit

4.1 b4.1 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Revenue

3.8 b4 b4.3 b4.2 b3.8 b3.9 b2.5 b2.4 b2.6 b2.6 b2.5 b2.6 b2.7 b5.5 b

Cost of goods sold

1.8 b2 b2.2 b2.1 b2 b2 b1.5 b1.4 b1.6 b1.5 b1.4 b1.5 b1.6 b3.2 b

Gross profit

1.9 b2 b2 b2.1 b1.8 b1.9 b1 b965 m972 m1.1 b1 b1.1 b1.1 b2.4 b

Gross profit Margin, %

52%50%48%49%48%49%42%41%38%42%42%43%42%43%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

2.7 b2.9 b2.2 b2.8 b

Inventories

3.5 b3.6 b1.6 b1.4 b

Current Assets

10 b10.4 b11.8 b6.6 b

PP&E

7.8 b8.7 b4.4 b4.3 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Cash

2.4 b2 b1.9 b2.1 b2.5 b6.7 b2 b2.2 b2.6 b2.6 b2.9 b3.8 b2.9 b2.9 b

Inventories

3.6 b3.7 b3.8 b3.7 b3.5 b3.8 b1.7 b1.7 b1.6 b1.6 b1.5 b1.5 b1.6 b1.6 b

Current Assets

9.6 b9.4 b9.5 b9.6 b9.7 b14.5 b11.1 b8 b6.8 b6.6 b6.6 b7.7 b7 b6.9 b

PP&E

7.5 b8 b8.2 b8.4 b8.5 b9 b4.3 b4.4 b4.3 b4.3 b4.3 b4.3 b4.6 b4.5 b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2 b2.5 b968 m5 b

Inventories

(311 m)(439 m)1.6 b80 m

Cash From Operating Activities

2.2 b3.2 b1.8 b1.7 b

Cash From Investing Activities

5.4 b(1.5 b)(1.8 b)(715 m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Net Income

544 m556 m520 m468 m430 m762 m763 m3.4 b4.6 b4.7 b272 m537 m389 m732 m

Depreciation and Amortization

497 m593 m189 m395 m599 m194 m378 m192 m387 m

Inventories

(439 m)(205 m)(26 m)(25 m)(11 m)(29 m)(38 m)(56 m)(134 m)

Accounts Payable

(103 m)(109 m)
USDY, 2018

Financial Leverage

1.9 x
Show all financial metrics
Report incorrect company information

Baxter International Online and Social Media Presence

Embed Graph
Report incorrect company information

Baxter International News and Updates

Global Nephrology and Urology Devices Market Analysis & Forecasts, 2018-2024: Key Players are Baxter International, Fresenius Medical Care, Boston Scientific & C.R. Bard

DUBLIN, Aug 31, 2018 /PRNewswire/ -- The "Nephrology and Urology Devices Market Analysis Report By Type (Dialysis, Benign Prostatic Hyperplasia, Endoscopy, Urinary Stone, Urinary Incontinence & Pelvic Organ Prolapse), And Segment Forecasts, 2018 - 2024" report has been added to...

Tissue Sealants Global Market 2018: Key Players – 3M Company, Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., C. R. Bard, Inc.

Tissue Sealants -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021 Posted via Industry Today. Follow us on Twitter @IndustryToday

Stem Cell Research in Cardiology Global Market 2018: Key Players – Athersys, Inc., Axordia Ltd, Baxter International, U.S. Stem Cell, Inc, Vericel Corporation

Stem Cell Research in Cardiology -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021 Posted via Industry Today. Follow us on Twitter @IndustryToday

Stem Cell Research in Cardiology Global Market 2018: Key Players – Athersys, Inc., Axordia Ltd, Baxter International, U.S. Stem Cell, Inc, Vericel Corporation

Stem Cell Research in Cardiology -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021 Posted via Industry Today. Follow us on Twitter @IndustryToday

Plasma Protein Therapeutics Market Overview, Analysis, Major Manufacturers, Production Price, Cost, Revenue & Market Status 2018 to 2023, focusing on Top Key Vendors like: : Baxter International, Biotest?, CSL Behring, China Biologics, GRIFOLS

The Global Plasma Protein Therapeutics Market Report includes a comprehensive analysis of the present market. The report starts with the basic Plasma Protein Therapeutics Market overview and then goes into each and every detail. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more
Report incorrect company information

Baxter International Company Life and Culture

Report incorrect company information